These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27487143)

  • 1. Targeting Zfp148 activates p53 and reduces tumor initiation in the gut.
    Nilton A; Sayin VI; Zou ZV; Sayin SI; Bondjers C; Gul N; Agren P; Fogelstrand P; Nilsson O; Bergo MO; Lindahl P
    Oncotarget; 2016 Aug; 7(35):56183-56192. PubMed ID: 27487143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of one copy of Zfp148 reduces lesional macrophage proliferation and atherosclerosis in mice by activating p53.
    Sayin VI; Khan OM; Pehlivanoglu LE; Staffas A; Ibrahim MX; Asplund A; Agren P; Nilton A; Bergström G; Bergo MO; Borén J; Lindahl P
    Circ Res; 2014 Oct; 115(9):781-9. PubMed ID: 25212213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zfp148 deficiency causes lung maturation defects and lethality in newborn mice that are rescued by deletion of p53 or antioxidant treatment.
    Sayin VI; Nilton A; Ibrahim MX; Ågren P; Larsson E; Petit MM; Hultén LM; Ståhlman M; Johansson BR; Bergo MO; Lindahl P
    PLoS One; 2013; 8(2):e55720. PubMed ID: 23405202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic profiling of the transcription factor Zfp148 and its impact on the p53 pathway.
    Zou ZV; Gul N; Lindberg M; Bokhari AA; Eklund EM; Garellick V; Patel AAH; Dzanan JJ; Titmuss BO; Le Gal K; Johansson I; Tivesten Å; Forssell-Aronsson E; Bergö MO; Staffas A; Larsson E; Sayin VI; Lindahl P
    Sci Rep; 2020 Aug; 10(1):14156. PubMed ID: 32843651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal overexpression of ZNF148 suppresses ApcMin/+ neoplasia.
    Law DJ; Labut EM; Merchant JL
    Mamm Genome; 2006 Oct; 17(10):999-1004. PubMed ID: 17019648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CKIα ablation highlights a critical role for p53 in invasiveness control.
    Elyada E; Pribluda A; Goldstein RE; Morgenstern Y; Brachya G; Cojocaru G; Snir-Alkalay I; Burstain I; Haffner-Krausz R; Jung S; Wiener Z; Alitalo K; Oren M; Pikarsky E; Ben-Neriah Y
    Nature; 2011 Feb; 470(7334):409-13. PubMed ID: 21331045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zfp281 (ZBP-99) plays a functionally redundant role with Zfp148 (ZBP-89) during erythroid development.
    Woo AJ; Patry CA; Ghamari A; Pregernig G; Yuan D; Zheng K; Piers T; Hibbs M; Li J; Fidalgo M; Wang JY; Lee JH; Leedman PJ; Wang J; Fraenkel E; Cantor AB
    Blood Adv; 2019 Aug; 3(16):2499-2511. PubMed ID: 31455666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
    Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
    EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription Factor ZBP-89 Drives a Feedforward Loop of β-Catenin Expression in Colorectal Cancer.
    Essien BE; Sundaresan S; Ocadiz-Ruiz R; Chavis A; Tsao AC; Tessier AJ; Hayes MM; Photenhauer A; Saqui-Salces M; Kang AJ; Shah YM; Győrffy B; Merchant JL
    Cancer Res; 2016 Dec; 76(23):6877-6887. PubMed ID: 27758879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZBP-89 promotes growth arrest through stabilization of p53.
    Bai L; Merchant JL
    Mol Cell Biol; 2001 Jul; 21(14):4670-83. PubMed ID: 11416144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis.
    Takeuchi A; Mishina Y; Miyaishi O; Kojima E; Hasegawa T; Isobe K
    Nat Genet; 2003 Feb; 33(2):172-6. PubMed ID: 12524542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
    Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
    BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
    Ghosh JC; Altieri DC
    Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression.
    Wang S; Zhang Y; Huang J; Wong CC; Zhai J; Li C; Wei G; Zhao L; Wang G; Wei H; Zhao Z; Yu J
    Cancer Res; 2019 Aug; 79(16):4086-4098. PubMed ID: 31239268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
    Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD
    Cancer Res; 2001 Dec; 61(24):8803-10. PubMed ID: 11751402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Krüppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations.
    Nandan MO; Ghaleb AM; McConnell BB; Patel NV; Robine S; Yang VW
    Mol Cancer; 2010 Mar; 9():63. PubMed ID: 20298593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
    Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.